Proteostasis Therapeutics: Still A Decent Upside?

2:48 pm ET, 12 Dec 2017

Cystic Fibrosis

Shares of Proteostasis Therapeutics (NASDAQ: PTI) more than doubled today after the company reported positive study results across all three of its Cystic Fibrosis (CF) pipeline programs. 

Proteostasis Therapeutics is focused on the development of new therapeutics that treat diseases caused by dysfunctional protein processing, such as cystic fibrosis. Its lead product candidate is PTI-428, a cystic fibrosis transmembrane conductance regulator.  The Company is also developing PTI-801, a corrector molecule; and PTI-808, a potentiator molecule. 

Here are some insights from S&P Capital IQ about PTI stock:

  • S&P Capital IQ scores the stock moderately high on Growth Stability and Financial Health.  Growth Stability shows how stable earnings growth and cash flow have been over time.  Financial Health looks at the Company’s debt and interest obligations to assess its financial state relative to its peers.
  • On the negative side, S&P Capital IQ believes that the Company’s overall earnings quality in relation to its peers is low, and the stock is overvalued.

Based on Finstead research, the average analyst price target for PTI is $9.50, and the range of analyst price targets is between $6.00 and $13.00.

PTI price target

Over the last year, PTI has returned -78.95%.  This return is lower than Technology sector (26.67%), Application Software industry (21.65%), S&P 500 (17.72%) returns.

Disclaimer: The news article above expresses the author’s opinion about the topic of the article. We strongly advise you not to base your investment decisions just on this article alone. If you’d like to become a writer for Finny Bites, please send us an email at hi@askfinny.com.

Proteostasis Therapeutics, Inc. (PTI) Stock Guide

Updated at: 3:40 pm ET, 12 Jul 2020

Before we start: if you're looking for PTI stock price, you can quickly find it out by visiting Finny and typing "PTI quote". If you're looking for a quick scoop on PTI stock (chart, price target, market cap, news and buy or sell analysis), go to Finny and look for "PTI". You'll get all this info in one place. Or you can just type "PTI news" to get the latest stock news.

Looking to buy or sell Proteostasis Therapeutics, Inc. (PTI)? Interested in getting the full scoop on PTI, including earnings and dividends, stock forecast, buy or sell analysis and key stats? If so, you came to the right place.

In this PTI stock guide, we'll address key questions about PTI, above and beyond what you can find on Yahoo Finance, Zacks, MarketWatch or Morningstar.

Here is what you'll be able to find in this guide:

Earnings and Dividends: earnings, earnings date, dividend rate and dividend yield;
Analyst Predictions: stock forecast and analyst ratings;
Analysis: Finny Score and buy or sell analysis;
Key Stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio, industry, sector, and number of employees.

And here is the list of questions we'll answer:
1. What are PTI earnings?
2. When is PTI earnings date?
3. What is PTI stock forecast (i.e., prediction)?
4. PTI buy or sell? What is PTI Finny Score?
5. What are the reasons to buy PTI? Why should I buy PTI stock?
6. What are the reasons to sell PTI? Why should I sell PTI stock?
7. What are PTI key stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of employees?

So let's start. Scroll down to the question that interests you the most.

Earnings and Dividends

1. What are PTI earnings?

PTI trailing 12-month earnings per share (EPS) is -$1.16.

2. When is PTI earnings date?

PTI earnings date is May 15, 2020.

Analyst Predictions

3. What is PTI stock forecast (i.e., prediction)?

Based on PTI analyst price targets, PTI stock forecast is $5.50 (for a year from now). That means the average analyst price target for PTI stock is $5.50. The prediction is based on 4 analyst estimates.

The low price target for PTI is $3.00, while the high price target is $8.00.

PTI analyst rating is Buy.

Analysis

4. PTI buy or sell? What is PTI Finny Score?

#{finnyScore:67}Our quantitative analysis shows 6 reasons to buy and 3 reasons to sell PTI, resulting in Finny Score of 67.

5. What are the reasons to buy PTI? Why should I buy PTI stock?

Here are the reasons to buy PTI stock:

6. What are the reasons to sell PTI? Why should I sell PTI stock?

Let's look at the reasons to sell PTI stock (i.e., the bear case):

  • PTI profitability is declining. The YoY profit margin change was -652.23 percentage points. See PTI profitability chart.
  • PTI short share of float is 5.10%. The stock is much more frequently shorted than the average industry, sector or S&P 500 stock. See PTI short share of float chart.
  • PTI short interest (days to cover the shorts) ratio is 3.68. The stock garners more short interest than the average industry, sector or S&P 500 stock. See PTI short interest ratio chart.

Key Stats

7. What are PTI key stats : revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of employees?

Let's look at the key statistics for PTI:

Metrics PTI
Price $1.64
Average Price Target / Upside $5.50 / 236.39%
Average Analyst Rating Buy
Forward Dividend Yield 0.00%
Industry Biotechnology
Sector Healthcare
Number of Employees 49
Market Cap $85.52M
Forward P/E Ratio -1.59
Price/Book Ratio 17.1
Revenue (TTM) $5M
YoY Quarterly Revenue Growth N/A
Profit Margin 0.00%

If you liked this analysis, check out Stock Guides for other stocks.

Disclaimer: The news article above expresses the author’s opinion about the topic of the article. We strongly advise you not to base your investment decisions just on this article alone. If you’d like to become a writer for Finny Bites, please send us an email at hi@askfinny.com.

Use Finny to ask any finance or investment question. Big or small. Personal or general.
Follow Us